Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemiaJingyu Zhang, Jinxin Che, Liteng Shen et al.|European Journal of Medicinal Chemistry|2023Cited by 14
Discovery of a New and Selective HPK1 PROTAC for Enhancing Tumor Immunotherapy through Eliminating GLK DegradationMingfei Wu, Xiaowu Dong, Xinfei Mao et al.|Journal of Medicinal Chemistry|2025Cited by 6